Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study - Wikidata - awgldk - TriplyDB

Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study

Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study

http://www.wikidata.org/entity/Q34015372

about

The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study.Data extraction and statistical errors: A quantitative critique of Gumley, Braehler, and Macbeth (2014).Potential of Oxytocin in the Treatment of Schizophrenia Oxytocin-augmented social cognitive skills training in schizophrenia.Agile delivery of protein therapeutics to CNS Oxytocin administration enhances controlled social cognition in patients with schizophrenia Association between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders.Efficacy of intranasal administration of artesunate in experimental cerebral malaria Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia.Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.Oxytocin and social cognition in affective and psychotic disorders.Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials.Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia.RETRACTED: Effect of intranasal oxytocin administration on psychiatric symptoms: A meta-analysis of placebo-controlled studies Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia.A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery.Oxytocin: parallel processing in the social brain?A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.Up-regulated expression of oxytocin mRNA in peripheral blood lymphocytes from first-episode schizophrenia patients.Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia.The effects of adjunctive intranasal oxytocin in patients with schizophrenia.Oxytocin and Schizophrenia Spectrum Disorders.A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.

P2860

Q31157357-470BA816-7DDD-4120-BE27-A53BCC94C0BA Q31163872-376E8352-EE67-47EB-B612-896B41D52FD4 Q33761384-C27D0BAB-24E6-4619-BDF2-886BAC3316A3 Q33923629-F701CA07-3708-4674-8640-AF91FFA9834D Q34079647-ED1C75E2-7422-43FA-BCD0-6AEDB5B8CF5B Q34790823-54169ACE-BA48-4852-8492-26F6B8705EB7 Q35003945-3F90C8F8-454F-4F26-AD5D-7B663FE495BB Q35060339-A2D00D98-D9B6-4285-ACC7-27106F9FDAF4 Q35116515-4C972EFD-756B-4242-9FDA-C5F0376950A5 Q35117441-6A4CD8BC-8F5D-4A12-B254-CC345C03F960 Q35646296-CDB884BC-1079-4E94-82A1-37A6A171C694 Q35754102-AF6666A4-0230-4B1F-9654-76E8BA70694A Q35854836-CB4C3FC0-4732-4DD6-94AB-66002D093E2E Q35940721-565522CC-2316-46DD-ABED-C6262706CC8D Q36767785-07FD5C8B-6891-4968-8F8E-EDD8FA267450 Q36821775-05EF7683-B9DD-475C-9777-205C7AD1DF5A Q38192728-48E444A9-D866-4E78-B66C-4FABA2F2F22C Q38442124-10B1CEF1-29CE-4175-BB61-F35845BB95B8 Q38593718-A1F91042-B0EF-4B7E-974F-E622C1FEFD6A Q38629117-8AA35596-DABE-40BF-AEC5-177161CEE2B2 Q38674187-DDAAFE2B-A1F1-4013-B407-0834B47FB3D0 Q38683538-66FAD397-72B7-4808-81F2-C0419675F354 Q47135868-DB15E30D-4165-4E30-91C6-E4187B7806FF Q47139082-626D2FFC-02AA-49C8-B0F3-62C562F81202 Q47580425-3CE0AA93-4EDE-44DD-BB91-FF1CB2E47C63 Q47631168-793872F0-F27B-482F-B548-25050B739DB6 Q47701023-2FF3AF19-F8C4-47F1-AFD1-0BCAB92C0136 Q48520616-F6605D9F-46D2-4B73-BB1B-7FE53C821A55

P2860

Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study

http://www.wikidata.org/entity/Q34015372

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Effects of adjunctive intranas ...... placebo controlled pilot study

@ast

Effects of adjunctive intranas ...... placebo controlled pilot study

@en

Effects of adjunctive intranas ...... placebo controlled pilot study

@nl

type

label

Effects of adjunctive intranas ...... placebo controlled pilot study

@ast

Effects of adjunctive intranas ...... placebo controlled pilot study

@en

Effects of adjunctive intranas ...... placebo controlled pilot study

@nl

prefLabel

Effects of adjunctive intranas ...... placebo controlled pilot study

@ast

Effects of adjunctive intranas ...... placebo controlled pilot study

@en

Effects of adjunctive intranas ...... placebo controlled pilot study

@nl

P1433

Q34015372-CC6AF12B-E4BD-4F60-8FBD-E0647947CDD5

P1476

Q34015372-471E8A07-F587-4683-A5C8-E4F5C066FC3E

P2093

Q34015372-02D3B4C0-E5DA-4D26-AE8D-DDA83F68DF8D

Q34015372-1BC52969-CC52-49AF-8D76-4EF52238FE6D

Q34015372-279A6D8C-AB07-48BE-878C-4A11C74CDAF5

Q34015372-2AF7ABFD-56D4-4319-AD1B-3D070953A6F0

Q34015372-3BF4B7F9-532A-435C-A51D-D80142CC32BB

Q34015372-3C94AAB7-8EB2-4DD2-A3FC-E2BB02DE368C

Q34015372-437E676C-C219-4AFD-A43B-08ACEEE219D7

Q34015372-4F92E5D2-5AD0-4A13-8BD4-B1DC28202C0B

Q34015372-5BFD35FB-F38B-43B1-A7CC-2DFD976B83E1

Q34015372-72FDF3D4-B0B5-4958-AE56-BB3A8E7FC881

P2860

Q34015372-067A9CC2-83F4-415E-8F15-BA231F5FDB8D

Q34015372-079F21F3-A82F-49E3-945D-45FFE4223A74

Q34015372-0C12E593-16A3-48E1-BCBA-4EE3ED746215

Q34015372-0EED9B36-87F6-4F2F-A92E-BC6F91E0FD35

Q34015372-129B4642-4282-4607-BE90-86B8B5F03BA6

Q34015372-1440B004-749D-473B-977A-EB2D7EE41C35

Q34015372-20E9CABE-D872-4C1F-98F9-06516D348B37

Q34015372-21825CA9-9C58-479F-A8BF-F6258580EF82

Q34015372-21C89F07-347B-4DF0-B0BC-26596D0643F9

Q34015372-2613BCDF-9F39-441D-9385-D1CBE64B6EF9

P304

Q34015372-ECB3CCC4-5B66-407C-8169-EFEC7AB8A1DB

P31

Q34015372-ECBCFE9C-E7B8-4C28-86F0-B8D502707596

P356

Q34015372-9AADD2E5-C49D-4678-A2ED-368BBCAB922E

P407

Q34015372-2D3DBE0A-4BC0-4D31-93D6-76782482795C

P433

Q34015372-223CAFB9-C9BC-442E-B65F-9C8AE3F69E61

P478

Q34015372-26347094-F02A-4493-A529-89D3817FC822

P577

Q34015372-7916FA89-9926-4CCC-A0D1-5F284AAE5F84

P5875

Q34015372-63D1EA75-0E52-4098-AE14-95CA94F8E458

P698

Q34015372-48FA9C8A-8CBE-4336-8EF9-5218AC43C863

P921

Q34015372-028DB02D-20FE-46D9-959F-FBCE11B44512

Q34015372-083E50F2-E71C-4D19-AA32-DAB09DABAEB9

Q34015372-F2140661-74A9-43E1-B493-AD1DEE47AB5C

P932

Q34015372-9C596597-CC89-432A-AC88-700F7B793D5C

P356

J.SCHRES.2013.01.001

P1433

Schizophrenia Research

P1476

Effects of adjunctive intranas ...... placebo controlled pilot study

@en

P2093

Alan Bellack

http://www.w3.org/2001/XMLSchema#string

Carlo Contoreggi

http://www.w3.org/2001/XMLSchema#string

Deanna L Kelly

http://www.w3.org/2001/XMLSchema#string

Fang Liu

http://www.w3.org/2001/XMLSchema#string

Gregory P Strauss

http://www.w3.org/2001/XMLSchema#string

Heidi J Wehring

http://www.w3.org/2001/XMLSchema#string

Jared Linthicum

http://www.w3.org/2001/XMLSchema#string

Mary R Lee

http://www.w3.org/2001/XMLSchema#string

Nicola Cascella

http://www.w3.org/2001/XMLSchema#string

Robert P McMahon

http://www.w3.org/2001/XMLSchema#string

P2860

Oxytocin increases trust in humans

The neurobiology of pair bonding

Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.

Olfactory dysfunction in schizophrenia: a qualitative and quantitative review.

Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification test

Olfactory hedonic judgment in patients with deficit syndrome schizophrenia.

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

Negative symptoms in patients with schizophrenia with special reference to the primary versus secondary distinction.

Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence.

Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress.

P304

110-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SCHRES.2013.01.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235647667

http://www.w3.org/2001/XMLSchema#string

P698

23415472

http://www.w3.org/2001/XMLSchema#string

P921

P932

4125132

http://www.w3.org/2001/XMLSchema#string